28 Days of the Hepatitis C Protease Inhibitor VX-950, in Combination With PEG-Interferon-ALFA-2a and Ribavirin, Is Well-Tolerated and Demonstrates Robust Antiviral Effects

✍ Scribed by E.J. Lawitz; M. Rodriguez–Torres; A. Muir; J. Keane; T. Kieffer; L. McNair; J.G. McHutchison

• Book ID: 119759397
• Publisher: Elsevier Science
• Year: 2006
• Tongue: English
• Weight: 48 KB
• Volume: 131
• Category: Article
• ISSN: 0016-5085
• DOI: 10.1053/j.gastro.2006.06.100